Q/C Technologies (QCLS) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.50, -7.06% vs the prior close of $0.54.
- Volume 230.53K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
QCLS slides 7.1% to $0.50, a 1-month low. Closed at $0.50, -7.06% vs the prior close of $0.54. Day range $0.50–$0.53, opened at $0.53.
QCLS daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — QCLS slides 7.1% to $0.50, a 1-month low
- Closed at $0.50, -7.06% vs the prior close of $0.54. Day range $0.50–$0.53, opened at $0.53.
- Volume was 230.53K shares, 0.0x its 50-day average of 6.32M — lighter than usual.
- Price is -66.9% vs its 50-day average ($1.51) and -84.6% vs its 200-day average ($3.26).
- 52-week range $0.42–$8.17; today's close sits at 1% of that range, 93.9% below the 52-week high.
Oct 16, 2026 — QCLS slides 3.5% to $0.54, a 1-month low
- Closed at $0.54, -3.55% vs the prior close of $0.56. Day range $0.52–$0.59, opened at $0.58.
- Volume was 123.03K shares, 0.0x its 50-day average of 6.32M — lighter than usual.
- Price is -65.4% vs its 50-day average ($1.56) and -83.6% vs its 200-day average ($3.27).
- 52-week range $0.42–$8.17; today's close sits at 2% of that range, 93.4% below the 52-week high.
Oct 15, 2026 — QCLS jumps 3.3% to $0.56
- Closed at $0.56, +3.33% vs the prior close of $0.54. Day range $0.54–$0.59, opened at $0.54.
- Volume was 131.90K shares, 0.0x its 50-day average of 6.31M — lighter than usual.
- Price is -65.2% vs its 50-day average ($1.60) and -83.1% vs its 200-day average ($3.29).
- 52-week range $0.42–$8.17; today's close sits at 2% of that range, 93.2% below the 52-week high.
Oct 14, 2026 — QCLS dips 1.3% to $0.54, 4 down days in a row
- Closed at $0.54, -1.28% vs the prior close of $0.55. Day range $0.52–$0.56, opened at $0.55.
- Volume was 156.90K shares, 0.0x its 50-day average of 6.32M — lighter than usual.
- Price is -67.3% vs its 50-day average ($1.65) and -83.7% vs its 200-day average ($3.31).
- 52-week range $0.42–$8.17; today's close sits at 2% of that range, 93.4% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — QCLS slides 5.7% to $0.55, 3 down days in a row
- Closed at $0.55, -5.69% vs the prior close of $0.58. Day range $0.54–$0.57, opened at $0.57.
- Volume was 228.70K shares, 0.0x its 50-day average of 6.31M — lighter than usual.
- Price is -67.8% vs its 50-day average ($1.70) and -83.6% vs its 200-day average ($3.33).
- 52-week range $0.42–$8.17; today's close sits at 2% of that range, 93.3% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — QCLS slides 7.9% to $0.58
- Closed at $0.58, -7.94% vs the prior close of $0.63. Day range $0.57–$0.62, opened at $0.62.
- Volume was 234.50K shares, 0.0x its 50-day average of 6.31M — lighter than usual.
- Price is -66.7% vs its 50-day average ($1.74) and -82.7% vs its 200-day average ($3.35).
- 52-week range $0.42–$8.17; today's close sits at 2% of that range, 92.9% below the 52-week high.
Oct 9, 2026 — QCLS dips 1.1% to $0.63
- Closed at $0.63, -1.10% vs the prior close of $0.64. Day range $0.60–$0.65, opened at $0.63.
- Volume was 131.40K shares, 0.0x its 50-day average of 6.31M — lighter than usual.
- Price is -64.7% vs its 50-day average ($1.78) and -81.3% vs its 200-day average ($3.38).
- 52-week range $0.42–$8.17; today's close sits at 3% of that range, 92.3% below the 52-week high.
Oct 8, 2026 — QCLS rises 0.8% to $0.64
- Closed at $0.64, +0.79% vs the prior close of $0.63. Day range $0.61–$0.65, opened at $0.64.
- Volume was 270.40K shares, 0.0x its 50-day average of 6.32M — lighter than usual.
- Price is -65.1% vs its 50-day average ($1.82) and -81.3% vs its 200-day average ($3.40).
- 52-week range $0.42–$8.17; today's close sits at 3% of that range, 92.2% below the 52-week high.
Oct 7, 2026 — QCLS slides 8.4% to $0.63
- Closed at $0.63, -8.41% vs the prior close of $0.69. Day range $0.62–$0.69, opened at $0.68.
- Volume was 291.20K shares, 0.0x its 50-day average of 6.32M — lighter than usual.
- Price is -66.0% vs its 50-day average ($1.86) and -81.5% vs its 200-day average ($3.42).
- 52-week range $0.42–$8.17; today's close sits at 3% of that range, 92.3% below the 52-week high.
Oct 6, 2026 — QCLS rises 1.3% to $0.69
- Closed at $0.69, +1.32% vs the prior close of $0.68. Day range $0.68–$0.73, opened at $0.68.
- Volume was 187.80K shares, 0.0x its 50-day average of 6.32M — lighter than usual.
- Price is -63.8% vs its 50-day average ($1.91) and -79.9% vs its 200-day average ($3.44).
- 52-week range $0.42–$8.17; today's close sits at 3% of that range, 91.6% below the 52-week high.
Oct 5, 2026 — QCLS slides 9.0% to $0.68, 4 down days in a row
- Closed at $0.68, -8.96% vs the prior close of $0.75. Day range $0.67–$0.74, opened at $0.73.
- Volume was 504.20K shares, 0.1x its 50-day average of 6.31M — lighter than usual.
- Price is -65.2% vs its 50-day average ($1.96) and -80.3% vs its 200-day average ($3.46).
- 52-week range $0.42–$8.17; today's close sits at 3% of that range, 91.7% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — QCLS slides 3.5% to $0.75, 3 down days in a row
- Closed at $0.75, -3.48% vs the prior close of $0.77. Day range $0.74–$0.81, opened at $0.77.
- Volume was 324.70K shares, 0.1x its 50-day average of 6.31M — lighter than usual.
- Price is -62.7% vs its 50-day average ($2.01) and -78.5% vs its 200-day average ($3.48).
- 52-week range $0.42–$8.17; today's close sits at 4% of that range, 90.8% below the 52-week high.
- That makes 3 straight losses.
QCLS bull case vs bear case (from the data)
- Insiders made 4 open-market purchases in the last 12 months.
- Share count down 95.4% in a year (buybacks).
- Price is -66.9% vs its 50-day average — short-term trend is down.
- Price is -84.6% vs its 200-day average — below the long-term trend line.
- Annual revenue fell 5.3% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $11.63M.
- High volatility: average daily move of 6.2% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
QCLS latest news & SEC filings
Every SEC filing by or about QCLS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Silverman Joshua received an award of 16,620 shares on Jul 10, 2026; now holds 133,455
- Silverman Joshua received an award of 77,390 shares on Oct 1, 2026; now holds 210,845
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Silverman Joshua received an award of 16,806 shares on Apr 13, 2026; now holds 116,835
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 17, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$6.62M (prior year -$1.80M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.79 (prior year -$51.10) (loss narrowed vs Jun 30, 2025)
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade QCLS
- Last results release: Nov 15, 2018 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 6.20% (largest 16.0%). That is a volatile stock.
- Liquidity: about 2.21M shares (≈$1.11M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.50 vs a range of $0.42–$8.17 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:100 on Sep 2, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Chelsea Sierra Voss bought 1,753 shares on Mar 30, 2026.
- Latest filings: 8-K Sep 18, 2026; 8-K Sep 11, 2026; 10-Q Aug 12, 2026.
- Share count: 8.19M shares outstanding (Aug 12, 2026), -95.4% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
QCLS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.53 | 0.53 | 0.50 | 0.50 | 230.53K |
| Oct 16, 2026 | 0.58 | 0.59 | 0.52 | 0.54 | 123.00K |
| Oct 15, 2026 | 0.54 | 0.59 | 0.54 | 0.56 | 131.90K |
| Oct 14, 2026 | 0.55 | 0.56 | 0.52 | 0.54 | 156.90K |
| Oct 13, 2026 | 0.57 | 0.57 | 0.54 | 0.55 | 228.70K |
| Oct 12, 2026 | 0.62 | 0.62 | 0.57 | 0.58 | 234.50K |
| Oct 9, 2026 | 0.63 | 0.65 | 0.60 | 0.63 | 131.40K |
| Oct 8, 2026 | 0.64 | 0.65 | 0.61 | 0.64 | 270.40K |
| Oct 7, 2026 | 0.68 | 0.69 | 0.62 | 0.63 | 291.20K |
| Oct 6, 2026 | 0.68 | 0.73 | 0.68 | 0.69 | 187.80K |
| Oct 5, 2026 | 0.73 | 0.74 | 0.67 | 0.68 | 504.20K |
| Oct 2, 2026 | 0.77 | 0.81 | 0.74 | 0.75 | 324.70K |
| Oct 1, 2026 | 0.83 | 0.83 | 0.76 | 0.77 | 597.80K |
| Sep 30, 2026 | 0.96 | 1.04 | 0.79 | 0.85 | 7.81M |
| Sep 29, 2026 | 0.82 | 0.91 | 0.77 | 0.89 | 975.20K |
| Sep 28, 2026 | 0.83 | 0.87 | 0.81 | 0.83 | 435.70K |
| Sep 25, 2026 | 1.00 | 1.05 | 0.85 | 0.87 | 1.24M |
| Sep 24, 2026 | 0.87 | 1.18 | 0.85 | 1.02 | 21.75M |
| Sep 23, 2026 | 0.88 | 0.92 | 0.83 | 0.88 | 1.03M |
| Sep 22, 2026 | 0.78 | 1.02 | 0.77 | 0.89 | 7.62M |
About Q/C Technologies
Q/C Technologies (QCLS) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1321834.
QCLS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Bruce Bernstein | Director | Apr 15, 2026 |
| Stephen Friscia | Director | Apr 15, 2026 |
| Mitchell Glass | Chief Medical Officer | Apr 15, 2026 |
| Joshua Silverman | Executive Chairman | Apr 15, 2026 |
| Chelsea Sierra Voss | Director | May 14, 2026 |
| Billy Joe White | Director | Apr 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yossef Ehrlichman | Chief Technology Officer | Sep 22, 2026 |
| Charles Todd Fagan | Chief Financial Officer | Aug 17, 2026 |
| Mitchell Glass | Chief Medical Officer | Apr 15, 2026 |
| Joshua Silverman | Executive Chairman | Apr 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 30, 2026 | Chelsea Sierra Voss | Buy | 1,753 | $3.15 |
| Mar 30, 2026 | Chelsea Sierra Voss | Buy | 1,753 | $3.15 |
| Mar 30, 2026 | Chelsea Sierra Voss | Buy | 1,753 | $3.15 |
| Mar 30, 2026 | Chelsea Sierra Voss | Buy | 1,753 | $3.15 |
QCLS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-11.63M | -8.66 | $-9.07M |
| Dec 31, 2024 | — | $-23.36M | -1,080.87 | $-8.98M |
| Dec 31, 2023 | — | $-4.00M | -5.33 | $-12.98M |
| Dec 31, 2022 | — | $-15.20M | -11.74 | $-12.27M |
| Dec 31, 2021 | — | $-29.89M | — | $-19.52M |
Latest balance sheet: total assets $22.87M, total liabilities $3.79M, cash $307.61K (as of Jun 30, 2026).
QCLS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Nov 15, 2018 | 8-K Item 2.02 (results) | — |
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Celldex Therapeutics (CLDX)Intellia Therapeutics (NTLA)Neogen (NEOG)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Insight Molecular Diagnostics (IMDX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on QCLS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.